Paul Shannon remembers enjoying an espresso on a spring morning in the old walled Italian city of Bergamo during one of his ...

Major companies like pharma giant GlaxoSmithKline (GSK) have established their largest ... in the UK capital and includes interactive maps that make it easier to navigate London’s eight life ...

Bearish flow noted in GSK (GSK) Pharma with 5,611 puts trading, or 3x expected. Most active are Mar-25 36.5 puts and 3/14 weekly 39.5 calls, with total volume in those strikes near 6,100 contracts.

It has been about a month since the last earnings report for GSK (GSK). Shares have added about ... Will the recent positive trend continue leading up to its next earnings release, or is Glaxo ...

GSK's long-acting asthma drug halved attacks in phase 3, backing up blockbuster hopes “Today’s data build on the body of evidence supporting depemokimab as an ultra-long-acting treatment and ...

Sales growth is expected to be weighted towards the second half of the year. GSK also announced plans to buyback up to £2 billion of shares over the next 18 months. GSK expects both core ...

Assuming those unusual expenses don't come up again, we'd therefore expect GSK to produce a higher profit next year, all else being equal. That might leave you wondering what analysts are ...

Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

GlaxoSmithKline Pharmaceuticals Ltd (GSK) on Friday announced its financial results for the third quarter ended December 31, 2024. According to the company’s exchange filing, it demonstrates ...